TY - JOUR
T1 - Metal-binding cyclodextrins
T2 - Synthesis and complexation with Zn2+ and Ga3+ cations towards antimicrobial applications
AU - Agnes, Marco
AU - Kasimati, Eleni Marina
AU - Inclán, Mario
AU - Thanassoulas, Angelos
AU - Miliotis, Georgios
AU - Malanga, Milo
AU - Benkovics, Gabor
AU - Nounesis, George
AU - García-España, Enrique
AU - Bouziotis, Penelope
AU - Lazarou, Yannis G.
AU - Miriagou, Vivi
AU - Mavridis, Irene M.
AU - Yannakopoulou, Konstantina
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Highly resistant bacteria producing metallo-β-lactamases (MBLs) to evade β-lactam antibiotics, constitute a major cause of life-threatening infections world-wide. MBLs exert their hydrolytic action via Zn2+ cations in their active center. Presently, there are no approved drugs to target MBLs and combat the associated antimicrobial resistance (AMR). Towards this issue, we have prepared a family of cyclodextrins substituted with iminodiacetic acid (IDA) on their narrow side, while the wider side is either unmodified or per-2,3-O-methylated. The molecules form strong coordination complexes with Zn2+ or Ga3+ cations in aqueous solution. Free and metal-complexed compounds have been thoroughly characterized regarding structures, pH-dependent ionization states, distribution of species in solution, pKa values and metal-binding constants. At neutral pH the multi-anionic hosts bind up to four Zn2+ or Ga3+ cations. In vitro, 50 μΜ of the compounds achieve complete re-sensitization of MBL-producing Gram-negative clinical bacterial strains resistant to the carbapenems imipenem and meropenem. Moreover, the radioactive complex [67Ga]Ga-β-IDACYD prepared, displays high radiochemical purity, sufficient stability both overtime and in the presence of human plasma apo-transferrin, thus providing an invaluable tool for future biodistribution and pharmacokinetic studies of β-IDACYD in vivo, prerequisites for the development of therapeutic protocols.
AB - Highly resistant bacteria producing metallo-β-lactamases (MBLs) to evade β-lactam antibiotics, constitute a major cause of life-threatening infections world-wide. MBLs exert their hydrolytic action via Zn2+ cations in their active center. Presently, there are no approved drugs to target MBLs and combat the associated antimicrobial resistance (AMR). Towards this issue, we have prepared a family of cyclodextrins substituted with iminodiacetic acid (IDA) on their narrow side, while the wider side is either unmodified or per-2,3-O-methylated. The molecules form strong coordination complexes with Zn2+ or Ga3+ cations in aqueous solution. Free and metal-complexed compounds have been thoroughly characterized regarding structures, pH-dependent ionization states, distribution of species in solution, pKa values and metal-binding constants. At neutral pH the multi-anionic hosts bind up to four Zn2+ or Ga3+ cations. In vitro, 50 μΜ of the compounds achieve complete re-sensitization of MBL-producing Gram-negative clinical bacterial strains resistant to the carbapenems imipenem and meropenem. Moreover, the radioactive complex [67Ga]Ga-β-IDACYD prepared, displays high radiochemical purity, sufficient stability both overtime and in the presence of human plasma apo-transferrin, thus providing an invaluable tool for future biodistribution and pharmacokinetic studies of β-IDACYD in vivo, prerequisites for the development of therapeutic protocols.
KW - Antibacterial
KW - Cyclodextrin
KW - Gallium
KW - Iminodiacetic acid
KW - Metallo-β-lactamase
KW - Zinc
UR - https://www.scopus.com/pages/publications/85170031901
U2 - 10.1016/j.carbpol.2023.121323
DO - 10.1016/j.carbpol.2023.121323
M3 - Article
C2 - 37739545
AN - SCOPUS:85170031901
SN - 0144-8617
VL - 321
JO - Carbohydrate Polymers
JF - Carbohydrate Polymers
M1 - 121323
ER -